NewslettersCell Therapy News CRISPR-Mediated MECOM Depletion Retards Tumor Growth by Reducing Cancer Stem Cell Properties in Lung Squamous Cell Carcinoma By lbeveridge - June 27, 2022 0 Forced expression of MECOM in lung squamous cell carcinoma cell lines promoted cancer stem cells (CSC) properties, and its knockout inhibited CSC phenotypes. [Molecular Therapy] AbstractFull ArticleGraphical Abstract